SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Welcure Drugs&Pharma reports Profit after tax of Rs -0.24 Mln, in the June 2021 quarter

12 Jul 2021 Evaluate
The sales is pegged at Rs. 0.22 millions for the June 2021 quarter. The mentioned figure indicates a decline of about -56.86% as against Rs. 0.51 millions during the year-ago period.The Net Loss for the quarter ended June 2021 is Rs. -0.24 millions as compared to Net Profit of Rs. 0.06 millions of corresponding quarter ended June 2020Operating profit Margin for the quarter ended June 2021 slipped to -0.24% as compared to 0.06% of corresponding quarter ended June 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202106 202006 % Var 202106 202006 % Var 202103 202003 % Var
Sales 0.22 0.51 -56.86 0.22 0.51 -56.86 1.33 0.83 60.24
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT -0.24 0.06 -500.00 -0.24 0.06 -500.00 0.55 -0.09 -711.11
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.24 0.06 -500.00 -0.24 0.06 -500.00 0.55 -0.09 -711.11
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -0.24 0.06 -500.00 -0.24 0.06 -500.00 0.55 -0.09 -711.11
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.24 0.06 -500.00 -0.24 0.06 -500.00 0.55 -0.09 -711.11
Equity 121.19 121.19 0.00 121.19 121.19 0.00 121.19 121.19 0.00
PBIDTM(%) -109.09 11.76 -1027.27 -109.09 11.76 -1027.27 41.35 -10.84 -481.37

Welcure Drugs&Pharma Share Price

0.31 -0.01 (-3.13%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 227.50
Adani Enterprises 2228.00
Amrapali Industries 17.36
Rashi Peripheral 474.40
PDS 294.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×